Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

被引：0
|
作者：
Harrysson, Sara [1 ,2 ]
Eloranta, Sandra [1 ]
Ekberg, Sara [1 ]
Enblad, Gunilla [3 ]
Jerkeman, Mats [4 ]
Hasselblom, Sverker [5 ]
Wahlin, Bjorn E. [2 ,6 ]
Andersson, Per-Ola [7 ,8 ]
Smedby, Karin E. [1 ,2 ]
机构：
[1] Karolinska Inst, Div Clin Epidemiol, Dept Med Solna, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Hematol, Solna, Sweden
[3] Akad Univ Hosp, Dept Oncol, Uppsala, Sweden
[4] Lund Univ, Inst Clin Sci, Dept Oncol & Pathol, Lund, Sweden
[5] Reg Halland, Dept Res Dev & Educ, Halmstad, Sweden
[6] Karolinska Inst, Div Hematol, Dept Med Huddinge, Stockholm, Sweden
[7] South Alvsborg Hosp, Dept Hematol, Boras, Sweden
[8] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-110672
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2975
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A MULTICENTER PHASE II STUDY OF BENDAMUSTINE WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Kim, W. S.
    Ando, K.
    Niitsu, N.
    Ogura, M.
    Takahashi, N.
    Uike, N.
    Eom, H. Seok
    Chae, Y. S.
    Tobinai, K.
    Terauchi, T.
    Tateishi, U.
    Tatsumi, M.
    Suh, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 94 - 94
  • [22] A Phase ll Trial to Evaluate the Efficacy of Fostamatinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
    Flinn, Ian
    Bartlett, Nancy L.
    Blum, Kristie A.
    Ardeshna, Kirit M.
    LaCasce, Ann
    Flowers, Christopher R.
    Shustov, Andrei R.
    Thress, Kenneth
    Zheng, Fred
    Skolnik, Jeffery
    Friedberg, Jonathan W.
    BLOOD, 2014, 124 (21)
  • [23] Diffuse large B-cell lymphoma (DLBCL)
    Renner, C.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S10 - S10
  • [24] CLINICAL FEATURES AND SURVIVAL OF PATIENTS WITH LATE RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Castillo-Giron, C.
    Rivas-Delgado, A.
    Dlouhy, I
    Rovira, J.
    Mozas, P.
    Rivero, A.
    Frigola, G.
    Balague, O.
    Baumann, T.
    Correa, J. G.
    Magnano, L.
    Jimenez-Vicente, C.
    Gomez, M.
    Delgado, J.
    Villamor, N.
    Campo, E.
    Gine, E.
    Lopez-Guillermo, A.
    HAEMATOLOGICA, 2020, 105 : 291 - 292
  • [25] Characteristics and Outcome of critically ill Patients with diffuse large B-Cell Lymphoma (DLBCL)
    Wohlfarth, P.
    Carlstroem, A.
    Staudinger, T.
    Clauss, S.
    Skrabs, K.
    Porpaczy, E.
    Schiefer, A. I.
    Valent, P.
    Jaeger, U.
    Sperr, W. R.
    Schellongowski, P.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2015, 110 (04) : 297 - 297
  • [26] Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study
    Ekberg, S.
    Harrysson, S.
    Jernberg, T.
    Szummer, K.
    Andersson, P. -O.
    Jerkeman, M.
    Smedby, K. E.
    Eloranta, S.
    JOURNAL OF INTERNAL MEDICINE, 2021, 290 (05) : 1048 - 1060
  • [27] Prognostic factors and outcome in 306 patients with diffuse large B-cell lymphoma (DLBCL)
    Oyan, Basak
    Tekuzman, Gulten
    Barista, Ibrahim
    Ozisik, Yavuz
    kars, Ayse
    Turker, Alev
    Yalcin, Suayib
    Guler, Nilufer
    Koc, Yener
    Kansu, Emin
    ANNALS OF ONCOLOGY, 2004, 15 : 153 - 153
  • [28] Prescriber Preference in Treatment of Relapsed or Refractory Multiple Myeloma (MM) and Diffuse Large B-Cell Lymphoma (DLBCL)
    Gupta, Supriya
    Ng, Lay She
    Munoz, Javier L.
    Bennani, N. Nora
    Khurana, Arushi
    Paludo, Jonas
    Cook, Joselle
    Kourelis, Taxiarchis
    Abdallah, Nadine
    Bisneto, Jose C. Villasboas
    Wang, Yucai
    Hampel, Paul J.
    Gertz, Morie A.
    Warsame, Rahma M.
    Hayman, Suzanne R.
    Iqbal, Madiha
    Leung, Nelson
    Kapoor, Prashant
    Kumar, Shaji
    Dingli, David
    Johnston, Patrick B.
    Ansell, Stephen M.
    Lin, Yi
    Durani, Urshila
    BLOOD, 2024, 144 : 7589 - 7590
  • [29] A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Kalakonda, Nagesh
    Cavallo, Federica
    Follows, George
    Goy, Andre
    Vermaat, Joost S. P.
    Casasnovas, Olivier
    Lavee, Orly
    Maerevoet, Marie
    Zijlstra, Josee
    Bakhshi, Sameer
    Bouabdallah, Reda
    Choquet, Sylvain
    Gurion, Ronit
    Hill, Brian
    Jaeger, Ulrich
    Sancho, Juan-Manuel
    Schuster, Michael
    Thieblemont, Catherine
    De la Cruz, Fatima
    Egyed, Miklos
    Mishra, Sourav
    Offner, Fritz
    Vassilakopoulos, Theodoros
    Warzocha, Krzysztof
    McCarthy, Daniel
    Ma, Xiwen
    Corona, Kelly
    Saint-Martin, Jean-Richard
    Joshi, Anita
    Shah, Jatin
    Van den Neste, Eric
    Canales, Miguel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S248 - S249
  • [30] Outcome in Unselected Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Following R-CHOP When Stem Cell Transplantation Is Not Feasible
    Kansara, Roopesh R.
    Savage, Kerry J.
    Villa, Diego
    Shenkier, Tamara
    Gerrie, Alina S.
    Klasa, Richard
    Hitz, Felicitas
    Scott, David W.
    Slack, Graham W.
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie H.
    BLOOD, 2014, 124 (21)
12345